Share this post on:

Product Name :
Mal-PEG4-COOH

Purity :
≥95%

CAS NO. :
518044-41-2

Synonyms:
Mal-PEG4-Acid;15-maleinimido-4,7,10,13-tetraoxapentadecanoic acid

Storage:
Store at -5°C,keep in dry and avoid sunlight.

Formula:
C15H23NO8

Classification :
Monodispersed PEGs > Carboxylic Acid(COOH) PEG

Molecular Weight:
345.3

Supplementary Information:
CAS No.: 518044-41-2 Synonyms: Mal-PEG4-Acid 15-maleinimido-4,7,10,13-tetraoxapentadecanoic acid Purity: ≥95% MF: C15H23NO8 MW: 345.3 Recommended Storage Condition: Store at -5°C,keep in dry and avoid sunlight. Uses: Applicated in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. Hot Products CLS-PEG4-NH-Mal Cat.No:MD095022

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Aldafermin medchemexpress
Infliximab site
Thrombomodulin Antibody (YA891): Thrombomodulin Antibody (YA891) is an unconjugated, approximately 95 kDa, rabbit-derived, anti-Thrombomodulin (YA891) monoclonal antibody. Thrombomodulin Antibody (YA891) can be used for: WB, ICC/IF, IP expriments in human background without labeling.

Share this post on: